©2024 Stanford Medicine
Examining Mu Opioid Mechanisms of Ketamine's Rapid Effects in OCD (MKET2)
Recruiting
I'm InterestedTrial ID: NCT05940324
Purpose
The purpose of this study is to understand how ketamine works in the brain to bring about a
reduction in OCD symptoms.
Official Title
Examining Mu Opioid Mechanisms of Ketamine's Rapid Effects in OCD (MKET2)
Stanford Investigator(s)
Carolyn Rodriguez
Professor of Psychiatry and Behavioral Sciences (Public Mental Health and Population Sciences)
Eligibility
Eligibility Criteria for Participants with OCD:
Inclusion Criteria:
- Ages 18-65
- Meet the criteria for OCD diagnosis
- Failed at least 1 prior trial of standard first-line OCD treatment
- Agree to the following lifestyle modifications: comply with requirements for fasting
prior to the Experimental Session, not enroll in any other interventional clinical
trials during the duration of the study, and commit to medication study procedures.
- Able to provide informed consent
Exclusion Criteria:
- prior naltrexone or ketamine use/exposure
- Any current or past medical/psychiatric condition that makes participation unsafe in
the opinion of the investigator or study physician
- Pregnant or nursing, or able to become pregnant and are not practicing an effective
means of birth control
- the presence of metal in the body that is contraindicated for MRI scans
Eligibility Criteria for Healthy Volunteers:
Inclusion Criteria:
- Ages 18-65
- Able to provide informed consent
Exclusion Criteria:
- current or past use of psychotropic medication
- pregnant or nursing females
- the presence of metal in the body that is contraindicated for MRI scans
Intervention(s):
drug: Ketamine
drug: Naltrexone Pill
other: Placebo pill
Recruiting
I'm InterestedContact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Pavithra Mukunda, MS
6504972578